Who owns DWTX?
Institutional ownership of Dogwood Therapeutics Inc. from Form 13F, Q2 2026
15 institutional managers reported holding Dogwood Therapeutics Inc. (DWTX) in Form 13F filings for Q2 2026, with 3,829,176 shares worth $6.2M. The largest reported holder was Armistice Capital, LLC. Managers that filed both quarters added a net 209,406 shares (+5.8%). 5 opened new positions and 3 sold out.
- Funds holding
- 15
- Value held
- $6.2M
- New / sold out
- 5 / 3
- Net shares, same filers
- +5.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of DWTX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Armistice Capital, LLC | $5.0M | 81.8% | 3,132,486 | Trimmed |
| Millennium Management LLC | $550K | 8.9% | 341,814 | New |
| Vanguard Capital Management LLC | $213K | 3.5% | 132,154 | Unchanged |
| Geode Capital Management, LLC | $142K | 2.3% | 88,298 | Added |
| Vanguard Fiduciary Trust Co | $101K | 1.6% | 62,736 | Unchanged |
| BlackRock, Inc. | $46K | 0.7% | 28,546 | Added |
| Northern Trust Corp | $38K | 0.6% | 23,779 | Unchanged |
| Citadel Advisors LLC | $19K | 0.3% | 11,742 | New |
| Tower Research Capital LLC (TRC) | $5K | 0.1% | 3,093 | Trimmed |
| Morgan Stanley | $4K | 0.1% | 2,222 | New |
| UBS Group AG | $3K | 0.0% | 1,860 | Trimmed |
| Jones Financial Companies LLLP | $264 | 0.0% | 160 | New |
| Barclays PLC | $253 | 0.0% | 157 | New |
| Activest Wealth Management | $193 | 0.0% | 120 | Unchanged |
| Group One Trading LLC | $14 | 0.0% | 9 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 3,829,176 DWTX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Millennium Management LLC New+$550K
- BlackRock, Inc. Added+$46K
- Citadel Advisors LLC New+$19K
- Geode Capital Management, LLC Added+$14K
- Morgan Stanley New+$4K
- Jones Financial Companies LLLP New+$264
- Barclays PLC New+$253
Biggest sellers in Q2 2026
- Armistice Capital, LLC Trimmed-$237K
- Goldman Sachs Group Inc Sold out-$31K
- Marshall Wace, LLP Sold out-$25K
- UBS Group AG Trimmed-$8K
- Tower Research Capital LLC (TRC) Trimmed-$8K
- BNP Paribas Financial Markets Sold out-$4
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $634K and sold $310K; 2 added and 3 trimmed.
Schedule 13D and 13G filings on DWTX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15ARMISTICE CAPITAL, LLC SCHEDULE 13G filed by Dogwood Therapeutics Inc.Schedule 13G
- 2025-03-17Orca Capital AG SCHEDULE 13G filed by Dogwood Therapeutics Inc.Schedule 13G
Questions about DWTX ownership
- Who owns DWTX stock?
- 15 institutional investment managers reported DWTX positions in their Form 13F filings for Q2 2026, holding 3,829,176 shares worth $6.2M in total. Armistice Capital, LLC reported the largest position.
- Are funds buying or selling DWTX?
- In Q2 2026, 5 managers opened new DWTX positions, 2 added, 3 trimmed and 3 sold out. Managers that filed in both quarters added a net 209,406 shares.
- How current is this DWTX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to DWTX by CUSIP. Options are left out. DWTX news and filings · DWTX insider trades · Top funds